Our data are compatible with those of Cherukuri and colleagues, who reported that myeloid cell-specific Cox-2 deletion in a Cox-2fl°x/fl°x x LysMCre/+ mouse model did not alter SI tumour number or size34. The gene discussed is PTGS2; the disease is neoplasm.